BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 11, 2002
View Archived Issues
Vasogen reports preliminary results from pilot study in CLL
Read More
Phase II Posurdex trial in persistent macular edema completes enrollment
Read More
Patent for p53/taxane combination therapy awarded to Aventis, licensed to Introgen
Read More
BioSante licenses triple hormone therapy technology
Read More
Liprostin pilot study to begin in January 2003
Read More
Hormone replacement therapies and statins in hypercholesterolemic postmenopausal women
Read More
AVP-923 for pseudobulbar affect in ALS
Read More
Adalimumab safe and effective in rheumatoid arthritis
Read More
Renegotiation of licensing agreement for Sarafem
Read More
New proapoptotic compounds identified at Cell Pathways
Read More
Inhibitors of CDK2, CDK5 and/or GSK-3 covered by Pfizer patent
Read More
Dual 5-HT2C/alpha2-adrenoceptor antagonists prepared and tested at Servier
Read More
Novel series of alpha4beta1/alpha4beta7 antagonists claimed by Merck
Read More
Neurogen synthesizes GLP-1 receptor modulators with utility in diabetes and eating disorders
Read More
New proline-based MMP inhibitors in early development at Aventis
Read More
MDX-060 has marked antitumor activity in CD30+ lymphoma-bearing mice
Read More
Antitumor activity of Geron's telomerase inhibitor reported in presentation at ASH meeting
Read More
HDAC inhibitor active against multiple myeloma in vitro and in animal model
Read More
Pipecolinate MDR modulators effective in modulating mitoxantrone efflux from AML cells
Read More
European approval for Avodart for benign prostatic hyperplasia
Read More
Micardis launched in Japan
Read More
Superior efficacy and safety demonstrated for GH-9001 versus other anticoagulants in rabbits
Read More
GTC begins study of rhATIII in patients with hereditary antithrombin deficiency
Read More
Advanced Biotherapy prepares IND for corneal transplant rejection therapy
Read More